Biography

Shervin J. Korangy has been a director since September 2017. Since 2019, he has served as the President and Chief Executive Officer and a member of the board of directors of BVI Medical, Inc., a TPG Capital portfolio company. BVI is a global developer, manufacturer and marketer of medical device products for ophthalmic surgery. Prior to being named President and Chief Executive Officer, Mr. Korangy served as the Chief Financial Officer and Chief Strategy Officer from 2017. Prior to joining BVI, Mr. Korangy served as a senior executive of Novartis Group AG, a diversified healthcare products company, from 2010 until 2017. During his nearly seven years at Novartis, he served in various international capacities spanning strategy, M&A, integrations, sales & marketing and general management including serving as the Global Head of Corporate Finance based in Switzerland. In 2011, Mr. Korangy co-founded Sight Sciences, Inc., a medical device company. Previously, he was a Managing Director at The Blackstone Group, one of the world’s largest alternative asset investment firms, which he joined in 1996. During his more than 14 years at Blackstone, he served both in the Restructuring & Special Situations business and in the Private Equity business. Mr. Korangy has served on The Wharton School’s Undergraduate Board since 2024 and has also served on The Wharton School’s Leadership Advisory Board, at the University of Pennsylvania, since 2019.